Liquidia (LQDA) EBITDA Margin Growth (1y) (2021 - 2026)
Liquidia (LQDA) EBITDA Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 304.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -157.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,330.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -650.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 8,630.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1,962.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 111.00 |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 118,171.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 118,171.00 |
| Dec 31, 2025 | 125,932.00 |
| Sep 30, 2025 | 65,948.00 |
| Jun 30, 2025 | 31,888.00 |
| Mar 31, 2025 | -16,634.00 |
| Dec 31, 2024 | -65,437.00 |
| Sep 30, 2024 | -25,136.00 |
| Jun 30, 2024 | -26,638.00 |
| Mar 31, 2024 | -76,360.00 |
| Dec 31, 2023 | -46,223.00 |
| Sep 30, 2023 | -12,585.00 |
| Jun 30, 2023 | -24,797.00 |
| Mar 31, 2023 | 20,896.00 |
| Dec 31, 2022 | 23,219.00 |
| Sep 30, 2022 | -5,631.00 |
| Jun 30, 2022 | -4,073.00 |
| Mar 31, 2022 | -12,257.00 |
| Dec 31, 2021 | 179,816.00 |